Progressing a drug product towards commercialisation involves increasing technical complexity, regulatory oversight, and supply risk - particularly for high-potency APIs, specialised formulations, and niche indications.
For UK pharmaceutical companies, manufacturing partners must demonstrate not only capability, but control, compliance, and consistency.
Why Choose Eirgen Pharma
Why Choose Eirgen Pharma?
Choosing the right CDMO is critical when developing and supplying high-potency or technically complex drug products. At Eirgen Pharma, we combine specialist capability, regulatory strategy, and a pragmatic partnership approach to support dependable outcomes.
Expertise
Specialist Execution for Complex & High-Potency Products
Eirgen Pharma brings focused expertise to programmes where potency, formulation complexity, and regulatory strategies demand specialist attention. Our teams apply deep technical knowledge, disciplined manufacturing practices and quality systems to support reliable, on-time progression from development through to commercial supply. ​
​
Reliable delivery - On Time, In Full.
Capacity
Right-Sized Manufacturing for Niche/Specialist Products
Eirgen Pharma is purpose-built to support low-to-high volume, high-value products that require control. Our manufacturing assets and operational approach allows us to support scale-up confidently, while maintaining the containment, oversight, and consistency required for high-potency and niche products.
​
Right-sized solutions that scale as your product progresses.
Flexibility
Manufacturing Solutions Shaped Around Your Programme
We understand that specialist and niche products rarely follow standard development or commercial pathways. Eirgen Pharma works collaboratively with partners to design practical, adaptable manufacturing solutions that reflect technical requirements, timelines, and commercial realities.
​
Quality outcomes delivered with operational efficiency.
Simplicity
Reducing Handovers for Greater Reliability
As an integrated CDMO, Eirgen Pharma supports development, manufacturing, and packaging within a coordinated framework. This helps minimize interfaces, reduce operational risk and maintain continuity as products move through critical phases of the lifecycle.
​
Greater agility and reduced supply risks.
Reducing Handovers for Greater Reliability
A Trusted CDMO Partner for US Pharma & Biotech
Eirgen Pharma is a European-based CDMO with proven experience supporting FDA-regulated products for the US market. We specialize in high-potency oral solid dose, softgel, and complex niche product development and manufacturing, that demand technical precision, and a responsive partnership.
​
US pharmaceutical and biotechnology companies work with Eirgen to de-risk development, shorten timelines, and secure reliable commercial supply for products where quality, containment, and compliance are non-negotiable.
 |  |  |
|---|---|---|
 |
Why US Companies Choose Eirgen Pharma
Built to meet FDA expectations
Our quality systems, documentation, and operational controls are designed to align with US FDA requirements, supporting smooth onboarding, tech transfer, and inspection readiness.
Agile CDMO partnership
Unlike large, multi-national companies, we offer hands-on technical support, faster decision-making, and direct access to experienced teams.
Specialists in high-potency and complexity
We focus on products others avoid - HPAPIs, niche indications, specialized formulations, and challenging dosage forms.
Secure European manufacturing for the US market
A dependable alternative to crowded or geopolitically exposed supply chains, with experience supplying US-bound products.
"Eirgen made outsourcing seamless. Their understanding of the US regulatory environment and ability to scale quickly gave us a clear advantage in a competitive market."
TK, New York
Core Capabilities for the US Market
Development & Manufacturing
-
High Potency Oral Solid Dose
-
Softgel Capsule Development & Manufacturing
-
Formulation Development & Optimization
-
Clinical to Commercial Scale-Up
-
Tech Transfer from US or Global Sites
Tech Transfer
-
Primary & Secondary Packaging
-
Serialization-Ready Processes (DSCSA-Aligned Where Possible)
-
Commercial Supply for US Distribution
Stability Checks
-
​Process Optimization & Stability Studies
-
Post-Approval Changes
-
Product Lifecycle Management
-
Continuous Improvement Support
Core Capabilities for the US Market
We support both human and animal health products across a broad range of indications, including;
Oncology &
High-Potency Compounds
Cardiovascular
CNS & Neurology
Specialty & Niche Products
Endocrinology &
Hormonal Therapies
.png)
Pain Management
Quality and compliance are central to how we operate.
-
FDA-inspection experience
-
EU GMP compliant facilities
-
Strong QA/QC oversight
-
Data integrity and audit readiness
-
Experienced regulatory and quality teams supporting US submissions
​
Our Goal: To help US partners move through development, approval, and commercial supply with confidence and clarity.